Cargando…

P1014: GERMINAL JAK2 MOLECULAR ALTERATIONS IN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS.

Detalles Bibliográficos
Autores principales:	Benetti, Andrea, Bertozzi, Irene, Cosi, Elisabetta, Luigia Randi, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431318/ http://dx.doi.org/10.1097/01.HS9.0000970960.23147.3f

Ejemplares similares

P1012: A NUMBER OF CONGENITAL ERYTHROCYTOSIS ARE MULTIGENIC
por: Benetti, A., et al.
Publicado: (2022)

Targeted NGS analysis reveals a complex genetic background of idiopathic erythrocytosis in a large Venetian family
por: Bertozzi, Irene, et al.
Publicado: (2023)

PB2043: ERYTHROCYTOSIS IN PATIENTS WITH TIBETAN EGLN1C127S MUTATION: IS IT A POLYMORPHISM IN PATIENTS LIVING AT SEA LEVEL?
por: Biagetti, G., et al.
Publicado: (2022)

P1012: CHARACTERIZING JAK2 MUTATED AND UNMUTATED ERYTHROCYTOSIS: A CLINICAL AND GENETIC COMPARISON
por: Mee Hwang, Sang, et al.
Publicado: (2023)

Hemochromatosis, Erythrocytosis and the JAK2 p.V617F Mutation
por: Langabeer, Stephen E.
Publicado: (2017)

Idiopathic erythrocytosis in IgA nephropathy
por: Mahesh, E., et al.
Publicado: (2017)

Systemic Mastocytosis and Essential Thrombocythemia: Case Report and Literature Overview
por: Cancian, Mauro, et al.
Publicado: (2019)

P1065: CONGENITAL ERYTHROCYTOSIS DUE TO HETEROZYGOUS VARIANTS IN THE BISPHOSPHOGLYCERATE MUTASE GENE
por: van Dijk, M. J., et al.
Publicado: (2022)

P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE
por: Reiter, A., et al.
Publicado: (2022)

Genetic analysis of 39 erythrocytosis and hereditary hemochromatosis‐associated genes in the Slovenian family with idiopathic erythrocytosis
por: Kristan, Aleša, et al.
Publicado: (2021)

Idiopathic erythrocytosis in a patient on chronic hemodialysis
por: Lee, Dong Hyun, et al.
Publicado: (2015)

Low incidence of EPOR mutations in idiopathic erythrocytosis
por: Filser, Mathilde, et al.
Publicado: (2020)

Prevalence and Causes of Anemia in Hospitalized Patients: Impact on Diseases Outcome
por: Randi, Maria Luigia, et al.
Publicado: (2020)

JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views
por: Gangat, Naseema, et al.
Publicado: (2021)

Germline JAK2 E846D Substitution as the Cause of Erythrocytosis?
por: Maaziz, Nada, et al.
Publicado: (2023)

The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis
por: Zagaria, Antonella, et al.
Publicado: (2022)

P1021: ERYTHROCYTOSIS, THROMBOCYTOSIS AND RATE OF RECURRENT THROMBOEMBOLIC EVENT - A POPULATION BASED COHORT STUDY
por: Enblom-Larsson, A., et al.
Publicado: (2022)

Poster 1014: Omalizumab efficiency in patients with allergic rhinitis and chronic sinusitis
por: Gonzalez-Diaz, Sandra Nora, et al.
Publicado: (2014)

Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis
por: Langabeer, Stephen E., et al.
Publicado: (2018)

SURPRISING ERYTHROCYTOSIS RESOLUTION AFTER MYOMECTOMY: MYOMATOUS ERYTHROCYTOSIS SYNDROME
por: Couillandre, Pauline, et al.
Publicado: (2023)

The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance
por: Girolami, Antonio, et al.
Publicado: (2019)

Molecular Pathways Involved in the Development of Congenital Erythrocytosis
por: Tomc, Jana, et al.
Publicado: (2021)

PReS-FINAL-1014: Role of MHC class I overexpression on muscle biopsy of patients with juvenile dermatomyositis
por: Sanchez-Manubens, J, et al.
Publicado: (2013)

Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX)
por: Girolami, Antonio, et al.
Publicado: (2018)

Absence of JAK2 V617F-mutated polycythemia vera in obstructive sleep apnea-associated erythrocytosis
por: Langabeer, Stephen E.
Publicado: (2022)

Investigation of Genetic Disturbances in Oxygen Sensing and Erythropoietin Signaling Pathways in Cases of Idiopathic Erythrocytosis
por: Dinardo, Carla Luana, et al.
Publicado: (2013)

MacOS support essentials 10.14
por: Dreyer, Arek, et al.
Publicado: (2019)

P1029: JAK2-CHIP IS ASSOCIATED WITH SIMILAR RISK OF CARDIOVASCULAR DISEASE AS JAK2-MPN
por: Grevet, Jeremy, et al.
Publicado: (2023)

Genetic Background of Congenital Erythrocytosis
por: McMullin, Mary Frances
Publicado: (2021)

Evolution of the Pyrethroids Target-Site Resistance Mechanisms in Senegal: Early Stage of the Vgsc-1014F and Vgsc-1014S Allelic Frequencies Shift
por: Diallo, Moussa, et al.
Publicado: (2021)

1014. Patient perspectives on pharmacy experiences for antiretroviral refills
por: Havens, Josh, et al.
Publicado: (2022)

P1428: IMPLICATIONS OF THE RUXOLITINIB (JAK1/JAK2 INHIBITOR) ON GRAFT-VERSUS-LEUKAEMIA EFFECT MEDIATED BY THE NK CELL.
por: Durán, C., et al.
Publicado: (2022)

Occurrence of L1014F and L1014S mutations in insecticide resistant Culex quinquefasciatus from filariasis endemic districts of West Bengal, India
por: Rai, Priyanka, et al.
Publicado: (2022)

Erythrocytosis associated with IgA nephropathy
por: Cohen, Camille, et al.
Publicado: (2021)

Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non‐neoplastic erythrocytosis patients
por: Mori, Yosuke, et al.
Publicado: (2022)

Retraction: Occurrence of L1014F and L1014S mutations in insecticide resistant Culex quinquefasciatus from filariasis endemic districts of West Bengal, India
Publicado: (2023)

P1004: EFFECT AND MOLECULAR MECHANISM OF TQ05105, A NOVEL SMALL MOLECULE INHIBITOR OF JAK2 IN MYELOPROLIFERATIVE NEOPLASM
por: Zhang, W., et al.
Publicado: (2022)

Excessive Erythrocytosis Is Not Associated With Altered Iron Homeostasis in Men From the World’s Highest City
por: Cairo, Gaetano, et al.
Publicado: (2023)

Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis
por: Delamare, Marine, et al.
Publicado: (2023)

1014. Factors Associated with Switching from Tenofovir Diproxil Phosphate to a Tenofovir Alafenamide Based Regimen in a Cohort with Unrestricted Access to Care and Medications
por: Ganesan, Anuradha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_llavu76kr5usu1ucf9r4savbsu